FJ Investments’s Gilead Sciences GILD Stock Holding History

FJ Investments’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-32,300	Closed	-$2.62M	–	170
2023 Q4	$2.62M	Buy	+32,300	New	+$2.51M	0.12%	85

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FJ Investments's GILD Position: Q1 2024 in Review

FJ Investments sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 32,300 shares — an estimated $2.62M sold.

FJ Investments first reported a position in GILD in Q4 2023 and held it in 1 quarter. The position peaked at $2.62M in Q4 2023. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

FJ Investments reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
FJ Investments sold 32,300 Gilead Sciences shares in Q1 2024, an estimated $2.62M.
FJ Investments first reported a position in Gilead Sciences in Q4 2023 and held it in 1 quarter.
FJ Investments's Gilead Sciences position peaked at $2.62M in Q4 2023.
1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on FJ Investments's 13F filing for Q1 2024, filed 15 May 2024.